ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Name: ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
License: Public Domain

Fang Wu

ClinicalTrials.gov · Datasets · License: Public Domain

advanced lung non-small cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174894
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.